Close Menu

NEW YORK (GenomeWeb News) — Stem cell therapeutics and research tools firm StemCells said today that it has transferred the Melbourne, Australia-based operations of recently acquired Stem Cell Sciences to StemCells' facilities in Cambridge, UK, and Palo Alto, Calif.

The move is part of StemCells' efforts to streamline operations following its estimated $4.8 million acquisition of SCS, which it originally announced in March and closed on April 1.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.